Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michele Caraglia

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Neoplasms

Physiology

Procedures

Antineoplastic Combined Chemotherapy Protocols

Living Beings

Mice

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Facchini Gaetano; Perri Francesco; Caraglia Michele; Pisano Carmela; Striano Stefano; Marra Luigi; Fiore Francesco; Aprea Pasquale; Pignata Sandro; Iaffaioli Rosario Vincenzo
New treatment approaches in renal cell carcinoma.
Sirangelo Ivana; Iannuzzi Clara; Vilasi Silvia; Irace Gaetano; Giuberti Gaia; Misso Gabriella; D'Alessandro Annamaria; Abbruzzese Alberto; Caraglia Michele
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac.
Marra Monica; Santini Daniele; Meo Giuseppina; Vincenzi Bruno; Zappavigna Silvia; Baldi Alfonso; Rosolowski Maciej; Tonini Giuseppe; Loeffler Markus; Lupu Ruth; Addeo Santolo Rosario; Abbruzzese Alberto; Budillon Alfredo; Caraglia Michele
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michele Caraglia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Facchini Gaetano; Perri Francesco; Caraglia Michele; Pisano Carmela; Striano Stefano; Marra Luigi; Fiore Francesco; Aprea Pasquale; Pignata Sandro; Iaffaioli Rosario Vincenzo
New treatment approaches in renal cell carcinoma.
Anti-cancer drugs 2009;20(10):893-900.
2009: Sirangelo Ivana; Iannuzzi Clara; Vilasi Silvia; Irace Gaetano; Giuberti Gaia; Misso Gabriella; D'Alessandro Annamaria; Abbruzzese Alberto; Caraglia Michele
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac.
Journal of cellular physiology 2009;221(2):412-23.
2009: Marra Monica; Santini Daniele; Meo Giuseppina; Vincenzi Bruno; Zappavigna Silvia; Baldi Alfonso; Rosolowski Maciej; Tonini Giuseppe; Loeffler Markus; Lupu Ruth; Addeo Santolo Rosario; Abbruzzese Alberto; Budillon Alfredo; Caraglia Michele
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells.
International journal of cancer. Journal international du cancer 2009;125(9):2004-13.
2009: Addeo Raffaele; De Santi M Serena; Del Prete Salvatore; Caraglia Michele
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
Cancer chemotherapy and pharmacology 2009;64(5):863-6.
2009: Marra Monica; Giudice Aldo; Arra Claudio; Vitale Giovanni; Castiglioni Sara; Nasti Guglielmo; Lombardi Angela; Ottaiano Alessandro; Facchini Gaetano; Iaffaioli Rosario V; Abbruzzese Alberto; Caraglia Michele
Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer: secret weapons in anti-cancer war?
Cancer biology & therapy 2009;8(18):1709-18.
2009: Caraglia M; Marra M; Tagliaferri P; Lamberts S W J; Zappavigna S; Misso G; Cavagnini F; Facchini G; Abbruzzese A; Hofland L J; Vitale G
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
Current cancer drug targets 2009;9(5):690-704.
2009: Pantano Francesco; Baldi Alfonso; Santini Daniele; Vincenzi Bruno; Borzomati Domenico; Vecchio Fabio Maria; Castri Federica; Antinori Armando; Caraglia Michele; Magistrelli Paolo; Coppola Roberto; Tonini Giuseppe
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
Cancer biology & therapy 2009;8(11):996-9.
2009: Vitale Giovanni; Caraglia Michele; van Koetsveld Peter M; Maroni Paola; Marra Monica; Colao Annamaria; Lamberts Steven W J; Cavagnini Francesco; Hofland Leo J
Potential role of type I interferons in the treatment of pituitary adenomas.
Reviews in endocrine & metabolic disorders 2009;10(2):125-33.
2009: Fogli Stefano; Caraglia Michele
Genotype-based therapeutic approach for colorectal cancer: state of the art and future perspectives.
Expert opinion on pharmacotherapy 2009;10(7):1095-108.
2009: Addeo Raffaele; Caraglia Michele; Del Prete Salvatore
Highlights of the Pananemia National Meeting of the Italian Southern Oncological Group (GOIM): pharmacological and molecular treatment of cancer-induced anemia. Sorrento, Italy, 19-20 December 2008.
Expert opinion on pharmacotherapy 2009;10(6):1089-93.
2009: Tassone Pierfrancesco; Di Martino Maria Teresa; Ventura Monica; Pietragalla Antonella; Cucinotto Iole; Calimeri Teresa; Bulotta Alessandra; Neri Paola; Caraglia Michele; Tagliaferri Pierosandro
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.
Cancer biology & therapy 2009;8(7):648-53.
2009: Addeo Raffaele; Caraglia Michele; Del Prete Salvatore
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives. 7 November 2008, Naples, Italy.
Expert opinion on investigational drugs 2009;18(3):373-8.
2009: Naviglio Silvio; Caraglia Michele; Abbruzzese Alberto; Chiosi Emilio; Di Gesto Davide; Marra Monica; Romano Maria; Sorrentino Annunziata; Sorvillo Luca; Spina Annamaria; Illiano Gennaro
Protein kinase A as a biological target in cancer therapy.
Expert opinion on therapeutic targets 2009;13(1):83-92.
2009: D'Angelo Velia; Crisci Stefania; Casale Fiorina; Addeo Raffaele; Giuliano Maria; Pota Elvira; Finsinger Paola; Baldi Alfonso; Rondelli Roberto; Abbruzzese Alberto; Caraglia Michele; Indolfi Paolo
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases.
Journal of experimental & clinical cancer research : CR 2009;28():39.
2008: Marra M; Lombardi A; Agostinelli E; Giuberti G; Zappavigna S; Tempera G; Vitale G; Bifulco M; Abbruzzese A; Caraglia M
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress.
Biochimica et biophysica acta 2008;1783(12):2269-78.
2008: Laezza Chiara; Fiorentino Laura; Pisanti Simona; Gazzerro Patrizia; Caraglia Michele; Portella Giuseppe; Vitale Mario; Bifulco Maurizio
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state.
Journal of molecular medicine (Berlin, Germany) 2008;86(12):1341-51.
2008: Neri Paola; Tagliaferri Pierosandro; Di Martino Maria Teresa; Calimeri Teresa; Amodio Nicola; Bulotta Alessandra; Ventura Monica; Eramo Pasqua Orietta; Viscomi Caterina; Arbitrio Mariamena; Rossi Marco; Caraglia Michele; Munshi Nikhil C; Anderson Kenneth C; Tassone Pierfrancesco
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
British journal of haematology 2008;143(4):520-31.
2008: Vincenzi Bruno; Patti Giuseppe; Galluzzo Sara; Pantano Francesco; Venditti Olga; Santini Daniele; Ruzzo Annamaria; Schiavon Gaia; Caraglia Michele; Marra Monica; Graziano Francesco; Tonini Giuseppe
Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis.
Oncology reports 2008;20(5):1213-20.
2008: Addeo Raffaele; De Rosa Carmine; Faiola Vincenzo; Leo Luigi; Cennamo Gregorio; Montella Liliana; Guarrasi Rosario; Vincenzi Bruno; Caraglia Michele; Del Prete Salvatore
Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Cancer 2008;113(9):2524-31.
2008: Lepretti Marilena; Costantini Susan; Ammirato Gaetano; Giuberti Gaia; Caraglia Michele; Facchiano Angelo M; Metafora Salvatore; Stiuso Paola
The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.
Experimental & molecular medicine 2008;40(5):541-9.
2008: Caraglia M; Carteni M; Dicitore A; Cassese D; De Maria S; Ferranti P; Giuberti G; Abbruzzese A; Stiuso P
Experimental study on vasoactive intestinal peptide (VIP) and its diaminopropane bound (VIP-DAP) analog in solution.
Amino acids 2008;35(2):275-81.
2008: Caraglia Michele; Marra Monica; Budillon Alfredo
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy.
Expert opinion on biological therapy 2008;8(7):1031-5.
2008: Addeo Raffaele; Faiola Vincenzo; Guarrasi Rosario; Montella Liliana; Vincenzi Bruno; Capasso Elena; Cennamo Gregorio; Rotundo Maria Saveria; Tagliaferri Pierosandro; Caraglia Michele; Del Prete Salvatore
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age.
Cancer chemotherapy and pharmacology 2008;62(2):285-92.
2008: Caraglia Michele; Marra Monica; Budillon Alfredo
Highlights of the annual meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors (Part I) 6 - 7 December 2007, Naples, Italy.
Expert opinion on biological therapy 2008;8(6):845-54.
2008: Colone Marisa; Calcabrini Annarica; Toccacieli Laura; Bozzuto Giuseppina; Stringaro Annarita; Gentile Massimo; Cianfriglia Maurizio; Ciervo Alessandra; Caraglia Michele; Budillon Alfredo; Meo Giuseppina; Arancia Giuseppe; Molinari Agnese
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
The Journal of investigative dermatology 2008;128(4):957-71.
2008: Addeo Raffaele; Nocera Vincenzo; Faiola Vincenzo; Vincenzi Bruno; Ferraro Gabriella; Montella Liliana; Guarrasi Rosario; Rossi Eugenio; Cennamo Gregorio; Tonini Giuseppe; Capasso Elena; Santini Daniele; Caraglia Michele; Del Prete Salvatore
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(2):209-14.
2008: Lentini A; Provenzano B; Caraglia M; Shevchenko A; Abbruzzese A; Beninati S
Impairment of the metastatic activity of melanoma cells by transglutaminase-catalyzed incorporation of polyamines into laminin and Matrigel.
Amino acids 2008;34(2):251-6.
2007: Addeo Raffaele; Montella Liliana; Baldi Alfonso; Cennamo Gregorio; Guarrasi Rosario; Faiola Vincenzo; Caraglia Michele; Del Prete Salvatore
Atypical cutaneous lymphoid hyperplasia induced by chemotherapy in a patient with advanced colon carcinoma.
Clinical colorectal cancer 2007;6(10):728-30.
2007: Caraglia Michele; Marra Monica; Viscomi Caterina; D'Alessandro Anna Maria; Budillon Alfredo; Meo Giuseppina; Arra Claudio; Barbieri Antonio; Rapp Ulf R; Baldi Alfonso; Tassone Pierfrancesco; Venuta Salvatore; Abbruzzese Alberto; Tagliaferri Pierosandro
The farnesyltransferase inhibitor R115777 (ZARNESTRA) enhances the pro-apoptotic activity of interferon-alpha through the inhibition of multiple survival pathways.
International journal of cancer. Journal international du cancer 2007;121(10):2317-30.
2007: Facchini G; Caraglia M; Santini D; Nasti G; Ottaiano A; Striano S; Maiolino P; Ruberto M; Fiore F; Tonini G; Budillon A; Iaffaioli R V; Zeppetella G L
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE).
Journal of experimental & clinical cancer research : CR 2007;26(3):307-12.
2007: Santini Daniele; Vincenzi Bruno; Galluzzo Sara; Battistoni Fabrizio; Rocci Laura; Venditti Olga; Schiavon Gaia; Angeletti Silvia; Uzzalli Federica; Caraglia Michele; Dicuonzo Giordano; Tonini Giuseppe
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4482-6.
2007: Marra M; Agostinelli E; Tempera G; Lombardi A; Meo G; Budillon A; Abbruzzese A; Giuberti G; Caraglia M
Anticancer drugs and hyperthermia enhance cytotoxicity induced by polyamine enzymatic oxidation products.
Amino acids 2007;33(2):273-81.
2007: Avallone Antonio; Di Gennaro Elena; Bruzzese Francesca; Laus Gianluca; Delrio Paolo; Caraglia Michele; Pepe Stefano; Comella Pasquale; Budillon Alfredo
Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
Anti-cancer drugs 2007;18(7):781-91.
2007: Chiosi Emilio; Spina Annamaria; Sorrentino Annunziata; Romano Maria; Sorvillo Luca; Senatore Giovanna; D'Auria Raffaella; Abbruzzese Alberto; Caraglia Michele; Naviglio Silvio; Illiano Gennaro
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007;27(7):589-97.
2007: Donadelli Massimo; Costanzo Chiara; Beghelli Stefania; Scupoli Maria Teresa; Dandrea Mario; Bonora Antonio; Piacentini Paolo; Budillon Alfredo; Caraglia Michele; Scarpa Aldo; Palmieri Marta
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine.
Biochimica et biophysica acta 2007;1773(7):1095-106.
2007: Budillon Alfredo; Di Gennaro Elena; Bruzzese Francesca; Rocco Monia; Manzo Giuseppe; Caraglia Michele
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents.
Recent patents on anti-cancer drug discovery 2007;2(2):119-34.
2007: Sagristani M; Caraglia M; Villa M R; Lucania A; Esposito M; Petriccione L; Improta S; Marra M; Iannaci G; Rossiello R; Mastrullo L
Concomitant occurrence of a primary renal NHL and of a papillary urothelial ureter cancer.
Journal of experimental & clinical cancer research : CR 2007;26(2):291-2.
2007: Nasti Guglielmo; Facchini Gaetano; Caraglia Michele; Franco Renato; La Mura Anna; Staiano Maria; Budillon Alfredo; Iaffaioli Rosario V; Ottaiano Alessandro
Concomitant occurrence of facial cutaneous and parotid gland metastases from rectal cancer after preoperative chemoradiotherapy.
Onkologie 2007;30(6):324-6.
2007: Addeo Raffaele; Crisci Stefania; D'Angelo Velia; Vincenzi Bruno; Casale Fiorina; Pettinato Guido; Donofrio Vittoria; Boldrini Renata; Alaggio Rita; Collini Paola; Bertorelle Roberta; Di Tullio Maria Teresa; Caraglia Michele; Terenziani Monica; Lo Curto Margherita; Indolfi Paolo
Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors.
Oncology reports 2007;17(5):1155-61.
2007: Lamberti A; Longo O; Marra M; Tagliaferri P; Bismuto E; Fiengo A; Viscomi C; Budillon A; Rapp U R; Wang E; Venuta S; Abbruzzese A; Arcari P; Caraglia M
C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.
Cell death and differentiation 2007;14(5):952-62.
2007: Caraglia Michele; Marra Monica; Leonetti Carlo; Meo Giuseppina; D'Alessandro Anna Maria; Baldi Alfonso; Santini Daniele; Tonini Giuseppe; Bertieri Raffaello; Zupi Gabriella; Budillon Alfredo; Abbruzzese Alberto
R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Journal of cellular physiology 2007;211(2):533-43.
2007: Lentini A; Mattioli P; Provenzano B; Abbruzzese A; Caraglia M; Beninati S
Role of the FAD-dependent polyamine oxidase in the selective formation of N(1),N(8)-bis(gamma-glutamyl)spermidine protein cross-links(1).
Biochemical Society transactions 2007;35(Pt 2):396-400.
2007: Vetrano A; Addeo R; Russo I; Meo G; De Rosa G; D'Anna F; Caraglia M
A case of clear renal cell cancer associated to meningioma and verrucous carcinoma of frontal region in an old patient.
Journal of experimental & clinical cancer research : CR 2007;26(1):157-9.
2007: Naviglio S; Spina A; Marra M; Sorrentino A; Chiosi E; Romano M; Improta S; Budillon A; Illiano G; Abbruzzese A; Caraglia M
Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007;27(2):129-36.
2007: Palmieri G; Montella L; Aiello C; Barbieri F; Di Vizio D; Schulz S; Beninati S; Budillon A; Caraglia M; Insabato L; Florio T
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract.
Amino acids 2007;32(3):395-400.
2007: Addeo Raffaele; Caraglia Michele; Faiola Vincenzo; Capasso Elena; Vincenzi Bruno; Montella Liliana; Guarrasi Rosario; Caserta Luigi; Del Prete Salvatore
Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life.
BMC cancer 2007;7():18.
2007: Palmieri Giovannella; Marino Mirella; Salvatore Marco; Budillon Alfredo; Meo Giuseppina; Caraglia Michele; Montella Liliana
Cetuximab is an active treatment of metastatic and chemorefractory thymoma.
Frontiers in bioscience : a journal and virtual library 2007;12():757-61.
2006: Santini Daniele; Schiavon Gaia; Angeletti Silvia; Vincenzi Bruno; Gasparro Simona; Grilli Claudia; La Cesa Annalisa; Virzí Vladimir; Leoni Valentina; Budillon Alfredo; Addeo Santolo R; Caraglia Michele; Dicuonzo Giordano; Tonini Giuseppe
Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
Recent patents on anti-cancer drug discovery 2006;1(3):383-96.
2006: Mancinelli Fabrizio; Caraglia Michele; Budillon Alfredo; Abbruzzese Alberto; Bismuto Ettore
Molecular dynamics simulation and automated docking of the pro-apoptotic Bax protein and its complex with a peptide designed from the Bax-binding domain of anti-apoptotic Ku70.
Journal of cellular biochemistry 2006;99(1):305-18.
2006: Caraglia Michele; Dicitore Alessandra; Giuberti Gaia; Cassese Diana; Lepretti Marilena; Cartenì Maria; Abbruzzese Alberto; Stiuso Paola
Effects of VIP and VIP-DAP on proliferation and lipid peroxidation metabolism in human KB cells.
Annals of the New York Academy of Sciences 2006;1070():167-72.
2006: Caraglia Michele; Marra Monica; Meo Giuseppina; Addeo Santolo R; Tagliaferri Pierosandro; Budillon Alfredo
EGF-R small inhibitors and anti-EGF-R antibodies: advantages and limits of a new avenue in anticancer therapy.
Recent patents on anti-cancer drug discovery 2006;1(2):209-22.
2006: Santini Daniele; Caraglia Michele; Vincenzi Bruno; Holen Ingunn; Scarpa Susanna; Budillon Alfredo; Tonini Giuseppe
Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates.
Nature clinical practice. Oncology 2006;3(6):325-38.
2006: Santini Daniele; Vincenzi Bruno; Hannon Rosemary A; Brown Janet E; Dicuonzo Giordano; Angeletti Silvia; La Cesa Annalisa; Coleman Robert E; Tonini Giuseppe; Budillon Alfredo; Caraglia Michele; Holen Ingunn
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.
Oncology reports 2006;15(5):1351-7.
2006: Caraglia Michele; Santini Daniele; Marra Monica; Vincenzi Bruno; Tonini Giuseppe; Budillon Alfredo
Emerging anti-cancer molecular mechanisms of aminobisphosphonates.
Endocrine-related cancer 2006;13(1):7-26.
2006: Bruzzese Francesca; Di Gennaro Elena; Avallone Antonio; Pepe Stefano; Arra Claudio; Caraglia Michele; Tagliaferri Pierosandro; Budillon Alfredo
Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):617-25.
2006: Magistrelli Paolo; Coppola Roberto; Tonini Giuseppe; Vincenzi Bruno; Santini Daniele; Borzomati Domenico; Vecchio Fabio; Valeri Sergio; Castri Federica; Antinori Armando; Nuzzo Gennaro; Caraglia Michele; Picciocchi Aurelio
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Journal of cellular biochemistry 2006;97(1):98-108.
2006: Caraglia Michele; Addeo Raffaele; Costanzo Raffaele; Montella Liliana; Faiola Vincenzo; Marra Monica; Abbruzzese Alberto; Palmieri Giovannella; Budillon Alfredo; Grillone Francesco; Venuta Salvatore; Tagliaferri Pierosandro; Del Prete Salvatore
Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
Cancer chemotherapy and pharmacology 2006;57(1):34-9.
2006: Santini D; Graziano F; Catalano V; Di Seri M; Testa E; Baldelli A M; Giordani P; La Cesa A; Spalletta B; Vincenzi B; Russo A; Caraglia M; Virzi V; Cascinu S; Tonini G
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.
BMC cancer 2006;6():125.
2005: Correale Pierpaolo; Fulfaro Fabio; Marsili Stefania; Cicero Giuseppe; Bajardi Eugenia; Intrivici Chiara; Vuolo Giuseppe; Carli Antonio Ferdinando; Caraglia Michele; Del Prete Salvatore; Greco Ettore; Gebbia Nicola; Francini Guido
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
Cancer chemotherapy and pharmacology 2005;56(6):563-8.
2005: Caraglia Michele; Marra Monica; Budillon Alfredo; Meo Giuseppina; Ricciardiello Filippo; Bismuto Ettore; Brachelente Giovanni; Francini Guido; Giordano Antonio; Correale Pierpaolo; Abbruzzese Alberto
Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation.
Cancer biology & therapy 2005;4(10):1159-67.
2005: Caraglia M; Beninati S; Giuberti G; D'Alessandro A M; Lentini A; Abbruzzese A; Bove G; Landolfi F; Rossi F; Lampa E; Costantino M
Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice.
Experimental & molecular medicine 2005;37(5):476-81.
2005: Caraglia Michele; Marra Monica; Mancinelli Fabrizio; D'Ambrosio Guglielmo; Massa Rita; Giordano Antonio; Budillon Alfredo; Abbruzzese Alberto; Bismuto Ettore
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells.
Journal of cellular physiology 2005;204(2):539-48.
2005: Correale Pierpaolo; Cusi Maria Grazia; Del Vecchio Maria Teresa; Aquino Angelo; Prete Salvatore Pasquale; Tsang Kwong Y; Micheli Lucia; Nencini Cristina; La Placa Marco; Montagnani Francesco; Terrosi Chiara; Caraglia Michele; Formica Vincenzo; Giorgi Giorgio; Bonmassar Enzo; Francini Guido
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):820-8.
2005: Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2005;63(2):114-7.
2005: Caraglia Michele; Montella Liliana; Addeo Raffaele; Costanzo Raffaele; Faiola Vincenzo; Del Prete Salvatore; Baldi Feliciano; Baldi Alfonso; Abbruzzese Alberto; Alloisio Marco
Conditions suggesting lymphoma: case 2. Mediastinal liposarcoma in a patient with previous testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3844-6.
2005: Budillon A; Bruzzese F; Di Gennaro E; Caraglia M
Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.
Current drug targets 2005;6(3):337-51.
2005: Caraglia M; Budillon A; Tagliaferri P; Marra M; Abbruzzese A; Caponigro F
Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications.
Current drug targets 2005;6(3):301-23.
2005: Tagliaferri P; Tassone P; Blotta S; Viscomi C; Grillone F; Budillon A; Caraglia M; Venuta S
Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways.
Current drug targets 2005;6(3):289-300.
2005: Iaffaioli R V; Formato R; Tortoriello A; Del Prete S; Caraglia M; Pappagallo G; Pisano A; Gebbia V; Fanelli F; Ianniello G; Cigolari S; Pizza C; Marano O; Pezzella G; Pedicini T; Febbraro A; Incoronato P; Manzione L; Ferrari E; Marzano N; Quattrin S; Pisconti S; Nasti G; Giotta G; Colucci G;
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
British journal of cancer 2005;92(9):1621-5.
2005: Caponigro Francesco; Formato Roberta; Caraglia Michele; Normanno Nicola; Iaffaioli Rosario Vincenzo
Monoclonal antibodies targeting epidermal growth factor receptor and vascular endothelial growth factor with a focus on head and neck tumors.
Current opinion in oncology 2005;17(3):212-7.
2005: Postiglione L; Di Domenico G; Caraglia M; Marra M; Giuberti G; Del Vecchio L; Montagnani S; Macri M; Bruno E M; Abbruzzese A; Rossi G
Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation.
International journal of oncology 2005;26(5):1193-201.
2005: Pelaia Girolamo; Cuda Giovanni; Vatrella Alessandro; Gallelli Luca; Caraglia Michele; Marra Monica; Abbruzzese Alberto; Caputi Mario; Maselli Rosario; Costanzo Francesco S; Marsico Serafino A
Mitogen-activated protein kinases and asthma.
Journal of cellular physiology 2005;202(3):642-53.
2005: Montella Liliana; Caraglia Michele; Addeo Raffaele; Costanzo Raffaele; Faiola Vincenzo; Abbruzzese Alberto; Del Prete Salvatore
Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease).
Annals of hematology 2005;84(3):192-3.
2005: Caraglia Michele; Marra Monica; Pelaia Girolamo; Maselli Rosario; Caputi Mario; Marsico Serafino A; Abbruzzese Alberto
Alpha-interferon and its effects on signal transduction pathways.
Journal of cellular physiology 2005;202(2):323-35.
2005: Tagliaferri Pierosandro; Caraglia Michele; Budillon Alfredo; Marra Monica; Vitale Giovanni; Viscomi Caterina; Masciari Serena; Tassone Pierfrancesco; Abbruzzese Alberto; Venuta Salvatore
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer.
Cancer immunology, immunotherapy : CII 2005;54(1):1-10.
2005: Addeo Raffaele; Caraglia Michele; Baldi Alfonso; D'Angelo Velia; Casale Fiorina; Crisci Stefania; Abbruzzese Alberto; Vincenze Bruno; Campioni Mara; Di Tullio Maria Teresa; Indolfi Paolo
Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL).
Cancer biology & therapy 2005;4(1):32-8.
2005: Caraglia M; Giuberti G; Marra M; Di Gennaro E; Facchini G; Caponigro F; Iaffaioli Rv; Budillon A; Abbruzzese A
Docetaxel induces p53-dependent apoptosis and synergizes with farnesyl transferase inhibitor r115777 in human epithelial cancer cells.
Frontiers in bioscience : a journal and virtual library 2005;10():2566-75.
2004: Caraglia Michele; Vitale Giovanni; Marra Monica; Budillon Alfredo; Tagliaferri Pierosandro; Abbruzzese Alberto
Alpha-interferon and its effects on signalling pathways within cells.
Current protein & peptide science 2004;5(6):475-85.
2004: Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio M T; Indolfi P
P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
Oncology reports 2004;12(6):1201-7.
2004: Boccellino M; Giuberti G; Quagliuolo L; Marra M; D'Alessandro A M; Fujita H; Giovane A; Abbruzzese Alberto; Caraglia Michele
Apoptosis induced by interferon-alpha and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells.
Journal of cellular physiology 2004;201(1):71-83.
2004: Mancinelli Fabrizio; Caraglia Michele; Abbruzzese Alberto; d'Ambrosio Guglielmo; Massa Rita; Bismuto Ettore
Non-thermal effects of electromagnetic fields at mobile phone frequency on the refolding of an intracellular protein: myoglobin.
Journal of cellular biochemistry 2004;93(1):188-96.
2004: Caraglia Michele; D'Alessandro Anna Maria; Marra Monica; Giuberti Gaia; Vitale Giovanni; Viscomi Caterina; Colao Annamaria; Prete Salvatore Del; Tagliaferri Pierosandro; Tassone Pierfrancesco; Budillon Alfredo; Venuta Salvatore; Abbruzzese Alberto
The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate.
Oncogene 2004;23(41):6900-13.
2004: Lamberti A; Caraglia M; Longo O; Marra M; Abbruzzese A; Arcari P
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article.
Amino acids 2004;26(4):443-8.
2004: Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Acetylation of proteins as novel target for antitumor therapy: review article.
Amino acids 2004;26(4):435-41.
2004: Caraglia M; Vitale G; Marra M; Del Prete S; Lentini A; Budillon A; Beninati S; Abbruzzese A
Translational and post-translational modifications of proteins as a new mechanism of action of alpha-interferon: review article.
Amino acids 2004;26(4):409-17.
2004: Lentini A; Abbruzzese A; Caraglia M; Marra M; Beninati S
Protein-polyamine conjugation by transglutaminase in cancer cell differentiation: review article.
Amino acids 2004;26(4):331-7.
2004: Addeo Raffaele; Caraglia Michele; Costanzo Raffaele; Faiola Vincenzo; Montella Liliana; Abbruzzese Alberto; Del Prete Salvatore
Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients.
Oncology reports 2004;12(1):135-40.
2004: Montella Liliana; Caraglia Michele; Abbruzzese Alberto; Soricelli Andrea; Prete Salvatore Del; Squame Giovanni; Salvatore Marco
Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
Experimental & molecular medicine 2004;36(3):268-73.
2004: Correale P; Messinese S; Caraglia M; Marsili S; Piccolomini A; Petrioli R; Ceciarini F; Micheli L; Nencini C; Neri A; Vuolo G; Guarnieri A; Abbruzzese A; Prete S D; Giorgi G; Francini G
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
British journal of cancer 2004;90(9):1710-4.
2004: Addeo Raffaele; Casale Fiorina; Caraglia Michele; D'Angelo Velia; Crisci Stefania; Abbruzzese Alberto; Di Tullio Maria Teresa; Indolfi Paolo
Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo.
Cancer biology & therapy 2004;3(5):470-6.
2003: Caraglia M; Marra M; Giuberti G; D'Alessandro A M; Baldi A; Tassone P; Venuta S; Tagliaferri P; Abbruzzese A
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells.
Journal of biochemistry 2003;133(6):757-65.
2003: Tassone P; Tagliaferri P; Viscomi C; Palmieri C; Caraglia M; D'Alessandro A; Galea E; Goel A; Abbruzzese A; Boland C R; Venuta S
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.
British journal of cancer 2003;88(12):1971-8.
2003: Di Gennaro Elena; Barbarino Marcella; Bruzzese Francesca; De Lorenzo Sonya; Caraglia Michele; Abbruzzese Alberto; Avallone Antonio; Comella Pasquale; Caponigro Francesco; Pepe Stefano; Budillon Alfredo
Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
Journal of cellular physiology 2003;195(1):139-50.
2003: Caraglia M; Tagliaferri P; Marra M; Giuberti G; Budillon A; Gennaro E Di; Pepe S; Vitale G; Improta S; Tassone P; Venuta S; Bianco A R; Abbruzzese A
EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells.
Cell death and differentiation 2003;10(2):218-29.
2003: Esposito Carla; Marra Monica; Giuberti Gaia; D'Alessandro Anna Maria; Porta Raffaele; Cozzolino Anna; Caraglia Michele; Abbruzzese Alberto
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells.
The Biochemical journal 2003;370(Pt 1):205-12.
2002: Vitale Giovanni; Ciccarelli Antonio; Caraglia Michele; Galderisi Maurizio; Rossi Riccardo; Del Prete Salvatore; Abbruzzese Alberto; Lupoli Giovanni
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.
Clinical chemistry 2002;48(9):1505-10.
2002: Caraglia Michele; Marra Monica; Giuberti Gaia; D'Alessandro Anna Maria; Beninati Simone; Lentini Alessandro; Pepe Stefano; Boccellino Mariarosaria; Abbruzzese Alberto
Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells.
Journal of biochemistry 2002;132(1):45-52.
2002: Pizzi Claudia; Caraglia Michele; Cianciulli Maria; Fabbrocini Antonietta; Libroia Anna; Matano Elide; Contegiacomo Alma; Del Prete Salvatore; Abbruzzese Alberto; Martignetti Angelo; Tagliaferri Pierosandro; Bianco Angelo Raffaele
Low-dose recombinant IL-2 induces psychological changes: monitoring by Minnesota Multiphasic Personality Inventory (MMPI).
Anticancer research 2002;22(2A):727-32.
2001: Facchiano A M; Stiuso P; Chiusano M L; Caraglia M; Giuberti G; Marra M; Abbruzzese A; Colonna G
Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A).
Protein engineering 2001;14(11):881-90.
2001: Vitale G; Fonderico F; Martignetti A; Caraglia M; Ciccarelli A; Nuzzo V; Abbruzzese A; Lupoli G
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.
British journal of cancer 2001;84(12):1586-90.
2001: Vitale G; Caraglia M; Ciccarelli A; Lupoli G; Abbruzzese A; Tagliaferri P; Lupoli G
Current approaches and perspectives in the therapy of medullary thyroid carcinoma.
Cancer 2001;91(9):1797-808.
2001: Caraglia M; Marra M; Giuberti G; D'Alessandro A M; Budillon A; del Prete S; Lentini A; Beninati S; Abbruzzese A
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis.
Amino acids 2001;20(2):91-104.
2000: Lentini A; Vidal-Vanaclocha F; Facchiano F; Caraglia M; Abbruzzese A; Beninati S
Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice.
Melanoma research 2000;10(5):435-43.
2000: Lentini A; Autuori F; Mattioli P; Caraglia M; Abbruzzese A; Beninati S
Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis.
European journal of cancer (Oxford, England : 1990) 2000;36(12):1572-7.
2000: Caraglia M; Budillon A; Vitale G; Lupoli G; Tagliaferri P; Abbruzzese A
Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.
European journal of biochemistry / FEBS 2000;267(13):3919-36.
2000: Vitale G; Tagliaferri P; Caraglia M; Rampone E; Ciccarelli A; Bianco A R; Abbruzzese A; Lupoli G
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2000;85(3):983-8.
1999: Budillon A; Di Gennaro E; Caraglia M; Barbarulo D; Abbruzzese A; Tagliaferri P
8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.
British journal of cancer 1999;81(7):1134-41.
1999: Caraglia M; Abbruzzese A; Leardi A; Pepe S; Budillon A; Baldassare G; Selleri C; Lorenzo S D; Fabbrocini A; Giuberti G; Vitale G; Lupoli G; Bianco A R; Tagliaferri P
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor.
Cell death and differentiation 1999;6(8):773-80.
1999: Caraglia M; Di Gennaro E; Barbarulo D; Marra M; Tagliaferri P; Abbruzzese A; Budillon A
Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.
FEBS letters 1999;447(2-3):203-8.
1999: Caraglia M; Tagliaferri P; Budillon A; Abbruzzese A
Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy.
Advances in experimental medicine and biology 1999;472():187-98.
1999: Stiuso P; Colonna G; Ragone R; Caraglia M; Hershey J W; Beninati S; Abbruzzese A
Structural organization of the human eukaryotic initiation factor 5A precursor and its site-directed variant Lys50-->Arg.
Amino acids 1999;16(1):91-106.
1998: Beninati S; Gentile V; Caraglia M; Lentini A; Tagliaferri P; Abbruzzese A
Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells.
FEBS letters 1998;437(1-2):34-8.
1998: Leardi A; Caraglia M; Selleri C; Pepe S; Pizzi C; Notaro R; Fabbrocini A; De Lorenzo S; Musicò M; Abbruzzese A; Bianco A R; Tagliaferri P
Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells.
British journal of haematology 1998;102(3):746-52.
1998: Tagliaferri P; Guarrasi R; Caraglia M; Morelli D; Fabbrocini A; Correale P; Bianco A R
Tumour cell resistance to non-MHC-restricted lymphocytes: molecular mechanisms and clinical implications.
Cancer immunology, immunotherapy : CII 1998;46(3):121-7.
1998: Tagliaferri P; Barile C; Caraglia M; Guarrasi R; Morelli D; Ricciardi B; Martignetti A; Librera M T; Matano E; Della Vecchia A; Catalano G; Famiani M; Palmieri G; Correale P; Bianco A R
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.
American journal of clinical oncology 1998;21(1):48-53.
1997: Caraglia M; Leardi A I; Improta S; Perin V; Ricciardi B; Arra C; Ferraro P; Fabbrocini A; Pinto A; Bianco A R; Tagliaferri P
Transient exposure to cytarabine increases peptide growth factor receptor expression and tumorigenicity of melanoma cells.
Anticancer research 1997;17(4A):2369-75.
1997: Caraglia M; Passeggio A; Beninati S; Leardi A; Nicolini L; Improta S; Pinto A; Bianco A R; Tagliaferri P; Abbruzzese A
Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells.
The Biochemical journal 1997;324 ( Pt 3)():737-41.
1997: Correale P; Tagliaferri P; Guarrasi R; Caraglia M; Giuliano M; Marinetti M R; Bianco A R; Procopio A
Extracellular adenosine 5' triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation.
Immunology letters 1997;55(2):69-78.
1996: Tagliaferri P; Correale P; Mottola M; de Simone G; Montesarchio V; Matano E; Rea A; Morabito A; Famiani M; Ciardiello F; Tortora G; Caraglia M; Barile C; Palmieri G; Bianco A R
High-dose recombinant interleukin-2/verapamil combination in advanced cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1436-7.
1996: Tagliaferri P; Tortora G; Guarrasi R; Damiano V; Ruggiero A; Morelli D; Caraglia M; Bianco R; di Isernia G; Pepe S; Arteaga C L; Langton-Webster B C; Bianco A R; Ciardiello F
Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):207-14.
1995: Caraglia M; Leardi A; Corradino S; Ciardiello F; Budillon A; Guarrasi R; Bianco A R; Tagliaferri P
alpha-Interferon potentiates epidermal growth factor receptor-mediated effects on human epidermoid carcinoma KB cells.
International journal of cancer. Journal international du cancer 1995;61(3):342-7.
1995: Correale P; Caraglia M; Fabbrocini A; Guarrasi R; Pepe S; Patella V; Marone G; Pinto A; Bianco A R; Tagliaferri P
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the beta 1 integrin profile of cultured human tumor cells.
Anti-cancer drugs 1995;6(2):285-90.
1995: Ciardiello F; Damiano V; Bianco C; di Isernia G; Ruggiero A; Caraglia M; Tagliaferri P; Baselga J; Mendelsohn J; Bianco A R
Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(2):161-7.
1994: Palmieri G; Morabito A; Rea A; Caraglia M; Tagliaferri P; Bianco A R
Cytosine arabinoside (Ara-C) plus alpha-interferon (alpha IFN) determine prolonged complete remissions in patients with aggressive non-Hodgkin's lymphoma partially responsive to first-line doxorubicin-containing regimens.
British journal of haematology 1994;88(2):421-3.
1994: Caraglia M; Libroia A M; Corradino S; Coppola V; Guarrasi R; Barile C; Genua G; Bianco A R; Tagliaferri P
Alpha-interferon induces depletion of intracellular iron content and upregulation of functional transferrin receptors on human epidermoid cancer KB cells.
Biochemical and biophysical research communications 1994;203(1):281-8.
1994: Tagliaferri P; Caraglia M; Muraro R; Pinto A; Budillon A; Zagonel V; Bianco A R
Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy.
Anti-cancer drugs 1994;5(4):379-93.
1994: Caraglia M; Pinto A; Correale P; Zagonel V; Genua G; Leardi A; Pepe S; Bianco A R; Tagliaferri P
5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):269-76.
1993: Caraglia M; Tagliaferri P; Correale P; Genua G; Pinto A; Del Vecchio S; Esposito G; Bianco A R
Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.
Cancer immunology, immunotherapy : CII 1993;37(3):150-6.
1993: Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco A R
CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
The Year in immunology 1993;7():90-5.
1992: Correale P; Procopio A; Celio L; Caraglia M; Genua G; Coppola V; Pepe S; Normanno N; Vecchio I; Palmieri G
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
Cancer immunology, immunotherapy : CII 1992;34(4):272-8.
1991: Budillon A; Tagliaferri P; Caraglia M; Torrisi M R; Normanno N; Iacobelli S; Palmieri G; Stoppelli M P; Frati L; Bianco A R
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
Cancer research 1991;51(4):1294-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michele Caraglia

Research Profile (preview)

Chemicals & Drugs

Anatomy

Disorders

Physiology

Procedures

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michele Caraglia (preview)

All Publications